January homes sales tank more than 8%, as Realtors say potential buyers are ‘struggling’

January homes sales tank more than 8%, as Realtors say potential buyers are ‘struggling’


Prospective buyers arrive during an open house at a home in Seattle, Washington, US, on Sunday, Jan. 18, 2026.

David Ryder | Bloomberg | Getty Images

High home prices, faltering supply and weaker consumer confidence in the economy all continue to weigh on the U.S. housing market.

Sales of previously owned homes in January dropped a wider-than-expected 8.4% from December to a seasonally adjusted, annualized rate of 3.91 million, according to the National Association of Realtors.  Sales were 4.4% lower than January 2025. That is the slowest pace since December 2023.

This count is based on closings, so contracts that were likely signed in November and December, when the average rate on the 30-year fixed mortgage didn’t move much before dropping slightly in January. That rate is now 6.1%, according to Mortgage News Daily.

Regionally, sales fell across the nation month-to-month but were down the most in the South and West.

“Affordability conditions are improving, with NAR’s Housing Affordability Index showing that housing is the most affordable it’s been since March 2022,” said Lawrence Yun, NAR’s chief economist in a release. “This is due to wage gains outpacing home price growth and mortgage rates being lower than a year ago. However, supply has not kept pace and remains quite low.”

He also noted on a call with reporters that potential buyers are “still struggling.”

Inventory came down from December but was still up 3.4% year over year. There were 1.22 million homes for sale at the end of January, which at the current sales pace is a 3.7 month supply. A six-month supply is considered a balanced market between buyer and seller.

Tighter supply kept home prices in positive territory. The median price for a home sold in January was $396,800, up 0.9% year over year and the highest January price on record.

“Homeowners are in a financially comfortable position as a result. Since January 2020, a typical homeowner would have accumulated $130,500 in housing wealth,” Yun added.

Homes are taking longer to sell, at 46 days this January versus 41 in January of last year. About 31% of sales were to first-time buyers, up from 28% a year ago.

Sales continue to be strongest on the higher end of the market; in fact, the only price segment in the positive from a year ago was the $1 million-plus range. Sales dropped the most for homes priced below $250,000.

Get Property Play directly to your inbox

CNBC’s Property Play with Diana Olick covers new and evolving opportunities for the real estate investor, delivered weekly to your inbox.

Subscribe here to get access today.



Source

Pricey NFL, NBA ownership stakes are pushing investors to smaller leagues and driving valuations higher
Business

Pricey NFL, NBA ownership stakes are pushing investors to smaller leagues and driving valuations higher

Trinity Rodman #2 of Washington Spirit evades Sarah Schupansky #11 of Gotham FC during the NWSL Championship 2025 final between Washington Spirit and NJ/NY Gotham FC at PayPal Park on November 22, 2025 in San Jose, California. Lyndsay Radnedge/isi Photos | Isi Photos | Getty Images A version of this article first appeared in the […]

Read More
Hershey says GLP-1s are driving higher gum and mint sales
Business

Hershey says GLP-1s are driving higher gum and mint sales

Packages of Ice Breakers spearmint mints Mints are displayed at a Costco Wholesale store on April 27, 2025 in San Diego, California. Kevin Carter | Getty Images Hershey is seeing higher sales for its mints and gum — thanks to the growing use of GLP-1 drugs. “We’ve also seen strong demand for gum and mints, […]

Read More
More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says
Business

More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says

More than 20,000 people have started taking Eli Lilly‘s GLP-1 pill Foundayo in its first few weeks on the market, Lilly CEO Dave Ricks told CNBC on Thursday. The FDA approved Lilly’s once-daily pill Foundayo earlier this month, making it the second oral GLP-1 drug behind Novo Nordisk’s Wegovy pill. Investors have been closely tracking […]

Read More